Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

BACKGROUND: Potential drug–drug interactions (PDDIs) in patients with cancer are common, but have not previously been quantified for oral anticancer treatment. We assessed the prevalence and seriousness of potential PDDIs among ambulatory cancer patients on oral anticancer treatment. METHODS: A sear...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leeuwen, R W F, Brundel, D H S, Neef, C, van Gelder, T, Mathijssen, R H J, Burger, D M, Jansman, F G A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619066/
https://www.ncbi.nlm.nih.gov/pubmed/23412102
http://dx.doi.org/10.1038/bjc.2013.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619066/
https://www.ncbi.nlm.nih.gov/pubmed/23412102
http://dx.doi.org/10.1038/bjc.2013.48

Ejemplares similares